Literature DB >> 22446990

Coagulation Day 2010: an Austrian survey on the routine of thromboprophylaxis in intensive care.

E Schaden1, P G Metnitz, G Pfanner, S Heil, T Pernerstorfer, P Perger, H Schoechl, D Fries, M Guetl, S Kozek-Langenecker.   

Abstract

PURPOSE: Venous thromboembolism (VTE) is a common but often overlooked life-threatening complication of critical illness. The aim of this cross-sectional survey was to assess current practice of thromboprophylaxis as well as adherence to international guidelines.
METHODS: After ethics committee approval, all intensive care units in Austrian hospitals treating adult patients were invited to participate in this web-based survey. Anonymized data on each patient treated at the participating intensive care units on Coagulation Day 2010 were collected using an electronic case report form. Risk assessment, choice and monitoring of anticoagulants, means of mechanical prophylaxis, and demographic data were recorded.
RESULTS: Data from 325 critically ill patients were collected. Patients had a median of four risk factors for thrombosis and 6 % suffered from VTE. Of the 325 patients, 80 % received low molecular weight heparins subcutaneously, 10 % received unfractionated heparin intravenously, 1 % received alternative anticoagulants and 9 % received no pharmacological prophylaxis. Mechanical prophylaxis was used in 49 % with a predominant use of graduated compression stockings. In 39 % a combination of pharmacological and mechanical prophylaxis was applied and 5 % received no prophylaxis at all. Overall guideline adherence was 40 % on Coagulation Day 2010.
CONCLUSION: Current practice of thromboprophylaxis is predominantly based on the administration of low molecular weight heparins prescribed at rather arbitrary doses without a discernible relationship to drug monitoring, thromboembolic risk factors, vasopressor use or fluid balance. The use of mechanical prophylaxis, evaluation of risk scores and overall guideline adherence must be further encouraged by education, training and communication.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22446990     DOI: 10.1007/s00134-012-2533-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  25 in total

Review 1.  Elastic compression stockings for prevention of deep vein thrombosis.

Authors:  Ashwin Sachdeva; Mark Dalton; Sachiendra V Amaragiri; Timothy Lees
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

2.  Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients.

Authors:  Deborah J Cook; Mark A Crowther; Maureen O Meade; Jim Douketis
Journal:  J Crit Care       Date:  2005-12       Impact factor: 3.425

3.  A survey of thromboprophylaxis management in patients with major trauma.

Authors:  Davide Imberti; Walter Ageno
Journal:  Pathophysiol Haemost Thromb       Date:  2005

4.  [Routine nursing measures for thrombosis prevention in a university hospital].

Authors:  Elfriede Fritz; Christa Them; Johann Michael Hackl
Journal:  Pflege       Date:  2005-02       Impact factor: 0.655

5.  Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery.

Authors:  L Bara; A Planes; M M Samama
Journal:  Br J Haematol       Date:  1999-02       Impact factor: 6.998

Review 6.  Novel oral anticoagulants: implications in the perioperative setting.

Authors:  Jerrold H Levy; Nigel S Key; Marc S Azran
Journal:  Anesthesiology       Date:  2010-09       Impact factor: 7.892

Review 7.  Epidemiology and risk factors for venous thrombosis.

Authors:  Mary Cushman
Journal:  Semin Hematol       Date:  2007-04       Impact factor: 3.851

8.  Determination of enoxaparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent.

Authors:  Eva Schaden; Andreas Schober; Stefan Hacker; Christian Spiss; Astrid Chiari; Sibylle Kozek-Langenecker
Journal:  Blood Coagul Fibrinolysis       Date:  2010-04       Impact factor: 1.276

Review 9.  Risk factors for venous thromboembolism.

Authors:  Frederick A Anderson; Frederick A Spencer
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

10.  Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study.

Authors:  Mirjam K Rommers; Netty Van der Lely; Toine C G Egberts; Patricia M L A van den Bemt
Journal:  Crit Care       Date:  2006-06-21       Impact factor: 9.097

View more
  11 in total

Review 1.  Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.

Authors:  Sigrid Beitland; Irene Sandven; Lill-Kristin Kjærvik; Per Morten Sandset; Kjetil Sunde; Torsten Eken
Journal:  Intensive Care Med       Date:  2015-05-14       Impact factor: 17.440

2.  ICM focus on thrombosis and bleeding.

Authors:  Morten Hylander Møller; Markus B Skrifvars; Elie Azoulay
Journal:  Intensive Care Med       Date:  2017-10-23       Impact factor: 17.440

3.  PROF-ETEV study: prophylaxis of venous thromboembolic disease in critical care units in Spain.

Authors:  Pablo García-Olivares; Jose Eugenio Guerrero; Pedro Galdos; Demetrio Carriedo; Francisco Murillo; Antonio Rivera
Journal:  Intensive Care Med       Date:  2014-08-20       Impact factor: 17.440

4.  A data-driven approach to optimized medication dosing: a focus on heparin.

Authors:  Mohammad M Ghassemi; Stefan E Richter; Ifeoma M Eche; Tszyi W Chen; John Danziger; Leo A Celi
Journal:  Intensive Care Med       Date:  2014-08-05       Impact factor: 17.440

5.  Year in review in Intensive Care Medicine 2012. II: Pneumonia and infection, sepsis, coagulation, hemodynamics, cardiovascular and microcirculation, critical care organization, imaging, ethics and legal issues.

Authors:  Massimo Antonelli; Marc Bonten; Maurizio Cecconi; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Salvatore M Maggiore; Jordi Mancebo; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2013-01-05       Impact factor: 17.440

6.  Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit.

Authors:  François Lauzier; John Muscedere; Eric Deland; Demetrios Jim Kutsogiannis; Michael Jacka; Diane Heels-Ansdell; Mark Crowther; Rodrigo Cartin-Ceba; Michael J Cox; Nicole Zytaruk; Denise Foster; Tasnim Sinuff; France Clarke; Patrica Thompson; Steven Hanna; Deborah Cook
Journal:  Crit Care       Date:  2014-04-25       Impact factor: 9.097

7.  Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative.

Authors:  Michael B Streiff; Howard T Carolan; Deborah B Hobson; Peggy S Kraus; Christine G Holzmueller; Renee Demski; Brandyn D Lau; Paula Biscup-Horn; Peter J Pronovost; Elliott R Haut
Journal:  BMJ       Date:  2012-06-19

Review 8.  Practices to prevent venous thromboembolism: a brief review.

Authors:  Brandyn D Lau; Elliott R Haut
Journal:  BMJ Qual Saf       Date:  2013-05-24       Impact factor: 7.035

9.  Rate of venous thromboembolism among surgical patients in Australian hospitals: a multicentre retrospective cohort study.

Authors:  Hassan Assareh; Jack Chen; Lixin Ou; Stephanie J Hollis; Kenneth Hillman; Arthas Flabouris
Journal:  BMJ Open       Date:  2014-10-03       Impact factor: 2.692

10.  A Survey of the Knowledge of Venous Thromboembolism Prophylaxis among the Medical Staff of Intensive Care Units in North China.

Authors:  Xiao Tang; Bing Sun; Yuanhua Yang; Zhaohui Tong
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.